| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kurki T et al. | Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin. | 1992 | Am. J. Obstet. Gynecol. | pmid:1733190 |
| Presser SC et al. | Simultaneous measurements of prostacyclin and thromboxane metabolites during the menstrual cycle. | 1991 | Am. J. Obstet. Gynecol. | pmid:1892191 |
| Nowak J et al. | Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. | 1987 | Am. J. Physiol. | pmid:3548440 |
| Foudi N et al. | Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits. | 2009 | Am. J. Physiol. Heart Circ. Physiol. | pmid:19783781 |
| Lupinetti MD et al. | Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. | 1989 | Am. Rev. Respir. Dis. | pmid:2508524 |
| Riutta A et al. | Selective solid-phase extraction of urinary 2,3-dinor-6-ketoprostaglandin F1 alpha for determination with radioimmunoassay. | 1994 | Anal. Biochem. | pmid:7978278 |
| Falardeau P et al. | Quantitative analysis of two dinor urinary metabolites of prostaglandin I2. | 1981 | Anal. Biochem. | pmid:7030131 |
| Stergioulas AT and Filippou DK | Effects of physical conditioning on lipids and arachidonic acid metabolites in untrained boys: a longitudinal study. | 2006 | Appl Physiol Nutr Metab | pmid:16900233 |
| Kühl PG et al. | Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension. | 1989 | Arch. Dis. Child. | pmid:2673060 |
| Foulon I et al. | Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. | 1993 | Arterioscler. Thromb. | pmid:8443146 |